367 results on '"Roberts, Paul C."'
Search Results
2. Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens
3. Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
4. Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
5. The Homological Conjectures
6. Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation.
7. Meeting Report From "Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID‐19 Pandemic".
8. A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adults
9. Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: implication for ovarian cancer risk
10. 2395. An Interim Report of the Safety, Reactogenicity, and Immunogenicity of a Self-amplifying mRNA (samRNA) COVID-19 Vaccine GRT-R910 as a Booster in Healthy Adults
11. The root closure of a ring of mixed characteristic
12. A Universal Influenza Vaccine : The Strategic Plan for the National Institute of Allergy and Infectious Diseases
13. A MINIMAL FREE COMPLEX ASSOCIATED TO THE MINORS OF A MATRIX
14. Cycles and Commutative Algebra
15. Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
16. Adams Operations, Localized Chern Characters, and the Positivity of Dutta Multiplicity in Characteristic 0
17. Host Cell Dependence of Viral Morphology
18. Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
19. A Characterization of Systems of Parameters
20. Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
21. Dietary Sphingolipids in Colon Cancer Prevention
22. Extracts from the Petrie Journals
23. An Archaeological Context for British Discoveries of Mummy Portraits in the Fayum
24. Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
25. Data from The Parity-Associated Microenvironmental Niche in the Omental Fat Band Is Refractory to Ovarian Cancer Metastasis
26. Supplementary Table 3 from The Parity-Associated Microenvironmental Niche in the Omental Fat Band Is Refractory to Ovarian Cancer Metastasis
27. Supplementary Table 4 from The Parity-Associated Microenvironmental Niche in the Omental Fat Band Is Refractory to Ovarian Cancer Metastasis
28. Supplementary Table 2 from The Parity-Associated Microenvironmental Niche in the Omental Fat Band Is Refractory to Ovarian Cancer Metastasis
29. Supplementary Table 1 from The Parity-Associated Microenvironmental Niche in the Omental Fat Band Is Refractory to Ovarian Cancer Metastasis
30. Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults – A randomized clinical trial
31. Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial
32. Local cohomology of Segre product type rings
33. A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults
34. 486. A/California/07/2009-pdm-like (H1N1) Influenza Virus Controlled Human Infection Model (CHIM) Activates Various Immune Cells Despite Induction of Mild Symptomatology
35. Ovarian tumor-initiating cells display a flexible metabolism
36. Biomechanical profile of cancer stem-like/tumor-initiating cells derived from a progressive ovarian cancer model
37. Regulation of Adaptive Immunity by Cells of the Innate Immune System: Bone Marrow Natural Killer Cells Inhibit T Cell Proliferation
38. A Multi-Center, Controlled Human Infection Study of Influenza A (H1N1)pdm09 in Healthy Adults
39. Metabolic changes during ovarian cancer progression as targets for sphingosine treatment
40. Dietary abscisic acid ameliorates influenza-virus-associated disease and pulmonary immunopathology through a PPARγ-dependent mechanism
41. SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
42. The effects of cancer progression on the viscoelasticity of ovarian cell cytoskeleton structures
43. Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
44. MCF10A and MDA-MB-231 human breast basal epithelial cell co-culture in silicon micro-arrays
45. Reactogenicity, Safety, and Serological and Cellular Immunogenicity of a Booster Dose of SARS-CoV-2 mRNA Prototype, Variant, and Bivalent Vaccines
46. SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
47. Homologous and Heterologous Covid-19 Booster Vaccinations
48. Fontaine rings and local cohomology
49. Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization
50. A Prime Ideal in a Polynomial Ring Whose Symbolic Blow-up is Not Noetherian
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.